APA (7th ed.) Citation

K, R., DK, H., R, B., P, S., S, A., JM, L., . . . M, S. (2023). The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma. Journal of hematology & oncology, 16(1), 88. https://doi.org/10.1186/s13045-023-01465-x

Chicago Style (17th ed.) Citation

K, Rejeski, et al. "The CAR-HEMATOTOX Score as a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-directed CAR-T for Relapsed/refractory Multiple Myeloma." Journal of Hematology & Oncology 16, no. 1 (2023): 88. https://doi.org/10.1186/s13045-023-01465-x.

MLA (9th ed.) Citation

K, Rejeski, et al. "The CAR-HEMATOTOX Score as a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-directed CAR-T for Relapsed/refractory Multiple Myeloma." Journal of Hematology & Oncology, vol. 16, no. 1, 2023, p. 88, https://doi.org/10.1186/s13045-023-01465-x.